AiCuris Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 64

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $6.68M

  • Investors
  • 8

AiCuris General Information

Description

Operator of a medical research agency intended to offer novel antiviral and antibacterial agents. The company's agency engages in the discovery, research, and development of antiviral and antibacterial agents to treat severe and potentially life-threatening infectious diseases, enabling physicians to offer effective health outcomes to their patients.

Contact Information

Website
www.aicuris.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Friedrich-Ebert-Street 475
  • Building 302
  • 42117 Wuppertal
  • Germany
+49 0202
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • Friedrich-Ebert-Street 475
  • Building 302
  • 42117 Wuppertal
  • Germany
+49 0202

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AiCuris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 03-Mar-2022 $6.68M Completed Clinical Trials - Phase 3
5. Grant 31-Jan-2018 Completed Clinical Trials - Phase 3
4. Grant 01-Nov-2017 Completed Clinical Trials - Phase 2
3. Later Stage VC Completed Startup
2. Early Stage VC (Series B) 23-Apr-2010 $74.8M $74.8M Completed Startup
1. Angel (individual) 01-Mar-2006 Completed Startup
To view AiCuris’s complete valuation and funding history, request access »

AiCuris Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a medical research agency intended to offer novel antiviral and antibacterial agents. The company's agency e
Drug Discovery
Wuppertal, Germany
64 As of 2024

Frederick, MD
 

Shelton, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AiCuris Competitors (24)

One of AiCuris’s 24 competitors is ImQuest BioSciences, a Corporation company based in Frederick, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImQuest BioSciences Corporation Frederick, MD
Nanoviricides Corporation Shelton, CT
The Zambon Group Private Debt Financed Bresso, Italy
Pfizer Pakistan Corporation Karachi, Pakistan
Ability Pharma Private Equity-Backed Barcelona, Spain
You’re viewing 5 of 24 competitors. Get the full list »

AiCuris Patents

  • 607

    Total Documents Applications and Grants

  • Total Patents Families

  • 253

    Granted

  • 26

    Pending

  • Expiring in next 12 mo

AiCuris Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3925595-A1 Ophthalmic formulation comprising n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl] acetamide hemihydrate Inactive 17-Jun-2020
EP-3906929-A1 Letermovir for use in the prevention and the treatment of coronavirus infections Inactive 08-May-2020
US-20220401553-A1 Parapoxvirus for conditioning for and treatment of coronavirus infections Pending 08-May-2020
AU-2021267148-A1 Parapoxvirus for conditioning for and treatment of coronavirus infections Pending 08-May-2020
ES-2926807-T3 Parapoxvirus for conditioning and treatment of coronavirus infections Active 08-May-2020 A61P31/14
To view AiCuris’s complete patent history, request access »

AiCuris Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AiCuris Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Commission Government
U.S. Food and Drug Administration Government
Bayer Schering Pharma Corporation Minority
Thomas Strüngmann Angel (individual) Minority
DOM Capital Group Family Office Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

AiCuris Subsidiaries (1)

Company Name Industry Location Founded
AiCuris (Prevymis Partial Royalty Interest) Buildings and Property Wuppertal, Germany
To view AiCuris’s complete subsidiaries history, request access »

AiCuris FAQs

  • When was AiCuris founded?

    AiCuris was founded in 2006.

  • Where is AiCuris headquartered?

    AiCuris is headquartered in Wuppertal, Germany.

  • What is the size of AiCuris?

    AiCuris has 64 total employees.

  • What industry is AiCuris in?

    AiCuris’s primary industry is Drug Discovery.

  • Is AiCuris a private or public company?

    AiCuris is a Private company.

  • What is AiCuris’s current revenue?

    The current revenue for AiCuris is .

  • How much funding has AiCuris raised over time?

    AiCuris has raised $74.8M.

  • Who are AiCuris’s investors?

    European Commission, U.S. Food and Drug Administration, Bayer Schering Pharma, Thomas Strüngmann, and DOM Capital Group are 5 of 8 investors who have invested in AiCuris.

  • Who are AiCuris’s competitors?

    ImQuest BioSciences, Nanoviricides, The Zambon Group, Pfizer Pakistan, and Ability Pharma are some of the 24 competitors of AiCuris.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »